Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01503190 · ClinicalTrials.gov registry record
The Immune System's Response to Young Women's Breast Cancer
A clinical trial of Breast Cancer and Breast Cancer and Pregnancy, sponsored by University of Colorado, Denver.
- Recruiting
- Registry status
- 800
- Enrollment target
- 5
- Study locations
NCT01503190 is a study of Breast Cancer and Breast Cancer and Pregnancy that is actively recruiting participants, run by University of Colorado, Denver. The registered enrollment target is 800 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (71% lower). The trial reports 5 study locations across 1 state.
The verdict
NCT01503190, a study of Breast Cancer and Breast Cancer and Pregnancy, is actively recruiting participants, sponsored by University of Colorado, Denver.
- RECRUITING
- Registry status
- 800 participants
- Enrollment target
- 5
- Study locations
Study Summary
This study plans to learn more about the immune system's response to breast cancer in young women.
Conditions Studied
Study Locations (5)
Colorado
- University of Colorado Denver - Aurora
- Denver Health Hospital Authority - Denver
- UCHealth Cherry Creek Medcial Center - Denver
- UCHealth Highlands Ranch Hospital - Highlands Ranch
- UCHealth Lone Tree Medical Center - Lone Tree
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 800 participants |
| Start Date | 2009-07-21 |
| Est. Completion | 2027-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01503190
The ClinicalTrials.gov registry entry for NCT01503190 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 800 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (71% lower). The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Breast Cancer appearing as the primary indexed condition, and to 0 interventions.
NCT01503190 reports 5 study locations spanning 1 distinct geographic area - top geographies include Colorado.
Frequently Asked Questions
What is clinical trial NCT01503190 about?
NCT01503190 is a clinical study titled "The Immune System's Response to Young Women's Breast Cancer". This study plans to learn more about the immune system's response to breast cancer in young women.
What is the current status of trial NCT01503190?
This trial is currently recruiting. The enrollment target is 800 participants. The study started on 2009-07-21. Estimated completion is 2027-07.
What conditions does trial NCT01503190 study?
This clinical trial studies the following conditions: Breast Cancer, Breast Cancer and Pregnancy.
Who is sponsoring clinical trial NCT01503190?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01503190 being conducted?
This trial has 5 study locations across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
RECRUITING
-
Surviving Daily Life
RECRUITING
-
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
RECRUITING
-
UNC Pleural Fluid Registry
RECRUITING
-
Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA
RECRUITING · NA
-
Post-operative Radiotherapy Omission in Selected Patients With Early Breast Cancer Trial International VErsion (PROSPECTIVE)
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.